Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-14

Clinical Trial Update: Long-term Real-world Study of Dupilumab in COPD : Patient Characteristics, Safety and Patient-reported Outcomes

View source ↗

Summary

This update describes an ongoing long-term real-world study evaluating dupilumab in patients with chronic obstructive pulmonary disease (COPD), focusing on pati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dupilumab (dupilumab)

Snippet

Sponsor: Sanofi | Conditions: Chronic Obstructive Pulmonary Disease COPD | Status: RECRUITING